TORRE, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 599
NA - Nord America 526
EU - Europa 283
SA - Sud America 109
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.529
Nazione #
US - Stati Uniti d'America 502
SG - Singapore 262
CN - Cina 125
BR - Brasile 87
VN - Vietnam 76
RU - Federazione Russa 75
IT - Italia 74
HK - Hong Kong 58
DE - Germania 30
JP - Giappone 29
GB - Regno Unito 21
IN - India 16
FI - Finlandia 15
PL - Polonia 14
CA - Canada 10
MX - Messico 10
AR - Argentina 9
NL - Olanda 9
ES - Italia 8
FR - Francia 8
AT - Austria 7
TR - Turchia 7
BD - Bangladesh 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
ID - Indonesia 4
EG - Egitto 3
IL - Israele 3
IQ - Iraq 3
LT - Lituania 3
PY - Paraguay 3
SE - Svezia 3
ZA - Sudafrica 3
JO - Giordania 2
KE - Kenya 2
RS - Serbia 2
UA - Ucraina 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 1.529
Città #
Singapore 146
San Jose 100
Ashburn 58
Hong Kong 56
Beijing 48
Los Angeles 34
Ho Chi Minh City 31
Rome 31
Tokyo 29
Council Bluffs 27
Santa Clara 20
New York 18
Hanoi 16
Engelhard 15
Helsinki 13
Buffalo 12
Orem 12
Munich 11
Moscow 10
Nuremberg 9
Dallas 8
Frankfurt am Main 8
Montreal 8
St. George 7
Suzhou 7
Warsaw 7
Mexico City 6
Milan 6
São Paulo 6
The Dalles 6
Chicago 5
Denver 5
Poplar 5
Redondo Beach 5
Thrissur 5
Biên Hòa 4
Brooklyn 4
Chandigarh 4
North Bergen 4
Rio de Janeiro 4
Amsterdam 3
Brno 3
Chennai 3
City of London 3
Curitiba 3
Hải Dương 3
Lauterbourg 3
London 3
Marano di Napoli 3
Mumbai 3
Phoenix 3
San Francisco 3
Stockholm 3
Vienna 3
Amman 2
Ankara 2
Belgrade 2
Buenos Aires 2
Carapicuíba 2
Conselheiro Lafaiete 2
Cuenca 2
Da Nang 2
Erbil 2
Gdansk 2
Gdynia 2
Guangzhou 2
Ha Long 2
Haiphong 2
Lappeenranta 2
Maceió 2
Manchester 2
Miami 2
Mislata 2
Nairobi 2
Naples 2
North Shields 2
Paris 2
Pesaro 2
Raleigh 2
Salvador 2
Shanghai 2
São Bernardo do Campo 2
Tampa 2
Taranto 2
Thái Bình 2
Tiền Hải 2
Agudos 1
Aksaray 1
Annapolis 1
Aracaju 1
Araçatuba 1
Astrakhan 1
Atlanta 1
Barcelona 1
Barueri 1
Barão de Cocais 1
Baton Rouge 1
Belford Roxo 1
Belo Horizonte 1
Bergamo 1
Totale 930
Nome #
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 90
ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. 87
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 85
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 83
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. 78
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 76
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 74
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 68
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 68
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 68
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 67
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 66
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study. 64
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 61
Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study. 61
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. 55
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 55
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. 52
Pathways sustaining HDV activity act independently from the size of HBV resevoir and are fueled by an abundant expression of HBsAg from integrated HBV-DNA 52
Total HIV-DNA quantification (automated Elitech InGenius platform) in antiretroviral treated people living with HIV: viro-immunological correlations 51
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir 51
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir 51
The burden of HDV chronic infection and the gaps in HDV screening across Europe: an urgent need to strengthen diagnostic strategies at pan-European level 22
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. 20
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 17
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. 16
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. 15
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity 15
Intra-hepatic HDV replicative activity can be sustained by HBsAg production from HBV-DNA integration and can modulate virological response to bulevirtide 14
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA 14
Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level 13
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study 11
HBsAg Isoforms as Innovative Biomarkers in Predicting Virological Response to Bulevirtide in Patients With Chronic Hepatitis D 9
Totale 1.629
Categoria #
all - tutte 5.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202471 0 0 0 0 0 0 0 0 0 59 3 9
2024/2025303 10 57 30 12 15 43 24 17 28 14 25 28
2025/20261.255 186 51 109 134 118 48 134 138 190 143 4 0
Totale 1.629